2012 site selection report

The US recession might be over, but the obstacles facing the biopharmaceutical industry are still plentiful. There’s the eurozone debt crisis, US healthcare reform, an inefficient FDA, and the list goes on. Combined, these factors create a landscape of uncertainty […]

Read More

Supply chains for a patient-centric world

Over the course of human history, we have seen two big advances in health outcomes. The first wave, beginning in the mid-19th century, came from the adoption of modern hygiene practices, which sharply reduced medical infections and improved post-surgery survival […]

Read More

FTC Approves Express Scripts/Medco Merger: Excerpts

The Federal Trade Commission has closed its investigation of Express Scripts, Inc.’s proposed acquisition of Medco Health Solutions. As a result of the evidence collected during an intensive eight-month investigation, we conclude that the proposed transaction is not likely to […]

Read More

Jobs and biopharma

The 2012–13 Occupational Outlook Handbook* has just been published by the Bureau of Labor Statistics of the US Dept. of Labor. That news might be important if you have a college-age child who is doing some long-term career planning, or […]

Read More

Some good news on drug shortage–finally

The ongoing crisis in short-supply drugs, which went from background noise to a top-level problem for many hospital networks over the past year has not been “fixed,” by any means. The current list, available at the Am. Soc. of Health-System […]

Read More

A scientific approach to site selection

The global drug and pharmaceutical market continues to grow, but not all geographic locations deliver equal value. Incremental revenue from mature markets continues to decline, while emerging markets continue to grow. This trend is creating a change in how companies […]

Read More